menu
    • menu

    Company profile for ARTBIO

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ARTBIONorway Flag
    Country
    Country
    Norway
    Address
    Address
    Gaustadall?en 21, 0349 Oslo, Norway
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://artbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/artbio-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/artbio_inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ARTBIO Gets FDA Clearance for Alpha Radioligand Therapy AB001 IND
    ARTBIO Gets FDA Clearance for Alpha Radioligand Therapy AB001 IND

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/artbio-announces-fda-clearance-of-ind-application-for-lead-alpha-radioligand-therapy-ab001-302549360.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    ARTBIO Secures $132M Series B Funding for Alpha Radioligand
    ARTBIO Secures $132M Series B Funding for Alpha Radioligand

    29 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/artbio-announces-132-million-series-b-financing-to-advance-pipeline-of-alpha-radioligand-therapies-and-expand-manufacturing-and-supply-chain-infrastructure-302515367.html

    PR NEWSWIRE
    29 Jul 2025
    Share Share
    Oncoinvent & ARTBIO To Collaborate On Radiopharma Lab Facilities
    Oncoinvent & ARTBIO To Collaborate On Radiopharma Lab Facilities

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241204708260/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    ARTbio Partners with 3B Pharma for Alpha Radioligand Therapy
    ARTbio Partners with 3B Pharma for Alpha Radioligand Therapy

    14 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/artbio-to-enter-into-licensing-and-research-partnership-with-3b-pharmaceuticals-to-advance-a-first-in-class-alpha-radioligand-therapy-for-solid-tumors-302303411.html

    PR NEWSWIRE
    14 Nov 2024
    Share Share
    ARTBIO Partners with 3B Pharma on Alpha Radioligand for Tumors
    ARTBIO Partners with 3B Pharma on Alpha Radioligand for Tumors

    13 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/artbio-to-enter-into-licensing-and-research-partnership-with-3b-pharmaceuticals-to-advance-a-first-in-class-alpha-radioligand-therapy-for-solid-tumors-302303411.html

    PR NEWSWIRE
    13 Nov 2024
    Share Share
    FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
    FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514522695/en/FogPharma-and-ARTBIO-Announce-Collaboration-to-Co-Develop-Multiple-Helicon%E2%84%A2-Enabled-Alpha-Particle-Radioligand-Therapies-for-the-Treatment-of-Cancer

    BUSINESSWIRE
    14 May 2024
    Share Share

    ABOUT THIS PAGE

    Contact ARTBIO and get a quotation

    ARTBIO is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of 228TH/212PB GENERATOR SYSTEM bulk with DMF offered by ARTBIO

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search